Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Becton, Dickinson, and Company

3 Medical Device Stocks Seeing Surge in Demand

From robotic surgery to smart diagnostics, the medical devices industry is transforming healthcare delivery. To capitalize on this trend, you might consider adding Boston Scientific Corp (BSX), Becton, Dickinson and Company (BDX), and The Cooper Companies (COO), which could boost your portfolio. Keep reading….

Do Wall Street Analysts Like Becton, Dickinson and Company Stock?

Do Wall Street Analysts Like Becton, Dickinson and Company Stock?

MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.

Becton, Dickinson and Company's Q1 2025 Earnings: What to Expect

Becton, Dickinson and Company's Q1 2025 Earnings: What to Expect

MedTech giant Becton, Dickinson and Company is expected to unveil its first-quarter results in the upcoming month and analysts expect a notable double-digit growth in earnings.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

3 Healthcare Innovators Advancing Medical Technology

The healthcare industry is set for growth due to evolving healthcare demands and the rapid evolution of medical technologies. Hence, investors might consider investing in healthcare stocks, Becton, Dickinson and Co. (BDX), Zimmer Biomet Holdings (ZBH), and Embecta (EMBC). Read more….

Top 3 Dividend Kings Trading at a Deep Discount Today

These three highly-rated dividend growth stocks are trading cheap. Find out if now is the time to buy.

3 Highly-Rated Dividend Stocks To Buy on the Dip

Discover 3 top income stocks with low payout ratios, strong buy ratings, and long-term growth potential.

Is Becton, Dickinson and Company Stock Underperforming the Dow?

Becton, Dickinson and Company have underperformed the Dow Jones Industrials Average over the past year, yet Wall Street analysts maintain a bullish outlook on the stock’s prospects.

inkl

Read news from The Economist, FT, and more,
with one subscription

Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company Earnings Preview: What to Expect

Becton, Dickinson and Company is poised to announce its fourth-quarter results next month, and analysts predict a double-digit growth in the company’s bottom-line figure.

3 Medical Device Stocks to Buy for Consistent Growth

3 Medical Device Stocks to Buy for Consistent Growth

The medical devices industry is on the verge of an incoming boom, fueled by its growing demand and technological advancements. In this evolving landscape, investors could scoop up shares of robust medical device stocks Alcon (ALC), Becton, Dickinson (BDX), and Abbott (ABT) for solid gains. Read more….

3 Dividend Aristocrats that Could Double The Dividend

3 Dividend Aristocrats that Could Double The Dividend

Discover three Dividend Aristocrats poised for dividend growth and long-term returns.

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Is Becton, Dickinson, and Company Stock Underperforming the Nasdaq?

Becton, Dickinson, and Company have recently underperformed in the Nasdaq, but Wall Street analysts are optimistic about the stock’s prospects.

Are Wall Street Analysts Predicting Becton, Dickinson, and Company Stock Will Climb or Sink?

Are Wall Street Analysts Predicting Becton, Dickinson, and Company Stock Will Climb or Sink?

While Becton, Dickinson, and Company has failed to surpass the broader market over the past year, Wall Street analysts are highly bullish on the stock’s prospects.

3 Top-Rated Dividend Kings Trading Near Their 52-Week Lows

3 Top-Rated Dividend Kings Trading Near Their 52-Week Lows

These quality companies all have something in common: They are trading a little off their 52-week lows and pay an ever-increasing dividend.

3 Highest-rated Dividend Aristocrats Ready for Massive Returns

3 Highest-rated Dividend Aristocrats Ready for Massive Returns

These three dividend stocks are fairly priced and could be on their way up.

Get all your
news in one place.

100’s of premium titles.
One news app.

3 Most Undervalued Dividend Kings To Buy Right Now

Picking up undervalued dividend stocks rewards investors with income and potential capital appreciation.

3 Undervalued Dividend Aristocrats Trading Just Above Their 52 Week Lows

Now is a perfect opportunity to pick up these quality companies trading around their 52-week lows - before they rebound.

Becton Dickinson & Co. (BDX) Earnings Moves: A Buy or Sell for Investors?

Becton Dickinson & Co. (BDX) is expected to report steady growth for its fiscal fourth quarter ended September 2023, scheduled to be released on November 9. While the stock is witnessing weakness over the past month, will the quarterly report be able to spur a rally? Read on.

Want Passive Income? Try These 3 Dividend Stocks

Despite a decline in inflation in July, persistent concerns over a potential recession could keep the market volatile in the upcoming months. Therefore, it could be wise to invest in dividend stocks AbbVie (ABBV), Emerson Electric (EMR), and Becton Dickinson (BDX) to navigate the market volatility with solid passive income.…

Get all your
news in one place.

100’s of premium titles.
One news app.

Are Medical Device Stocks Good Investments During a Recession?

The stock market has witnessed a massive sell-off lately on concerns over the Fed’s aggressive interest rate hikes to fight the decade-high inflation. Many analysts expect the economy to slip into recession due to the Fed’s monetary policy tightening. Since the medical device industry is known to be one of…

People

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

Abbott Laboratories

General Dynamics

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Monetary Policy

Medical Technology

Places

251,583 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play